These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27995876)

  • 21. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation.
    Vasudevan Nampoothiri R; Chen S; Pasic I; Al-Shaibani Z; Lam W; Michelis FV; Kim DDH; Viswabandya A; Gerbitz A; Lipton JH; Kumar R; Mattsson J; Law AD
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):134-140. PubMed ID: 33049225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and biological characteristics of childhood acute myeloid leukemia with EVI1 gene positive expression].
    Jiang M; Li XQ; Hu D; Qiu YN; Zhang ZQ; Zhang BY; Han J; Jin RM
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):129-34. PubMed ID: 24568904
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of high EVI1 expression in AML patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation in first CR.
    He X; Wang Q; Cen J; Qiu H; Sun A; Chen S; Wu D
    Bone Marrow Transplant; 2016 Jul; 51(7):921-7. PubMed ID: 27042849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome.
    Levy ER; Parganas E; Morishita K; Fichelson S; James L; Oscier D; Gisselbrecht S; Ihle JN; Buckle VJ
    Blood; 1994 Mar; 83(5):1348-54. PubMed ID: 8118036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
    Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ
    Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia.
    Vázquez I; Maicas M; Cervera J; Agirre X; Marin-Béjar O; Marcotegui N; Vicente C; Lahortiga I; Gomez-Benito M; Carranza C; Valencia A; Brunet S; Lumbreras E; Prosper F; Gómez-Casares MT; Hernández-Rivas JM; Calasanz MJ; Sanz MA; Sierra J; Odero MD
    Haematologica; 2011 Oct; 96(10):1448-56. PubMed ID: 21750091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical characteristics and prognosis of
    Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
    Morishita K; Parganas E; William CL; Whittaker MH; Drabkin H; Oval J; Taetle R; Valentine MB; Ihle JN
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3937-41. PubMed ID: 1570317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
    Sitailo S; Sood R; Barton K; Nucifora G
    Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
    Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
    Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5.
    Poirel H; Rack K; Delabesse E; Radford-Weiss I; Troussard X; Debert C; Leboeuf D; Bastard C; Picard F; Veil-Buzyn A; Flandrin G; Bernard O; Macintyre E
    Blood; 1996 Mar; 87(6):2496-505. PubMed ID: 8630416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Review: Aberrant EVI1 expression in acute myeloid leukaemia.
    Hinai AA; Valk PJ
    Br J Haematol; 2016 Mar; 172(6):870-8. PubMed ID: 26729571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
    Duan WB; Gong LZ; Jia JS; Zhu HH; Zhao XS; Jiang Q; Zhao T; Wang J; Qin YZ; Huang XJ; Jiang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):990-995. PubMed ID: 29263470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EVI1 expression in acute myeloid leukaemia.
    Langabeer SE; Rogers JR; Harrison G; Wheatley K; Walker H; Bain BJ; Burnett AK; Goldstone AH; Linch DC; Grimwade D;
    Br J Haematol; 2001 Jan; 112(1):208-11. PubMed ID: 11167805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with
    Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant DNA hypermethylation signature in acute myeloid leukemia directed by EVI1.
    Lugthart S; Figueroa ME; Bindels E; Skrabanek L; Valk PJ; Li Y; Meyer S; Erpelinck-Verschueren C; Greally J; Löwenberg B; Melnick A; Delwel R
    Blood; 2011 Jan; 117(1):234-41. PubMed ID: 20855866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia.
    Yamakawa N; Kaneda K; Saito Y; Ichihara E; Morishita K
    PLoS One; 2012; 7(1):e30706. PubMed ID: 22295105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).
    Suzukawa K; Parganas E; Gajjar A; Abe T; Takahashi S; Tani K; Asano S; Asou H; Kamada N; Yokota J
    Blood; 1994 Oct; 84(8):2681-8. PubMed ID: 7919381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia.
    Kiehlmeier S; Rafiee MR; Bakr A; Mika J; Kruse S; Müller J; Schweiggert S; Herrmann C; Sigismondo G; Schmezer P; Krijgsveld J; Gröschel S
    Leukemia; 2021 Nov; 35(11):3127-3138. PubMed ID: 33911178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.